(Q48747552)

http://europepmc.org/abstract/MED/28637687

15 February 2018

title

Inhibition of CDK4/6 by Palbociclib Significantly Extends Survival in Medulloblastoma Patient-Derived Xenograft Mouse Models (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6939669&resulttype=core&format=json

13 May 2020

0 references

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6939669&resulttype=core&format=json

13 May 2020

author name string

Michelle L Cook Sangar

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6939669&resulttype=core&format=json

13 May 2020

Laura A Genovesi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6939669&resulttype=core&format=json

13 May 2020

Madison W Nakamoto

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6939669&resulttype=core&format=json

13 May 2020

Melissa J Davis

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6939669&resulttype=core&format=json

13 May 2020

Sue E Knobluagh

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6939669&resulttype=core&format=json

13 May 2020

Pengxiang Ji

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6939669&resulttype=core&format=json

13 May 2020

Amanda Millar

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6939669&resulttype=core&format=json

13 May 2020

James M Olson

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6939669&resulttype=core&format=json

13 May 2020

language of work or name

English

0 references

publication date

21 June 2017

1 reference

http://europepmc.org/abstract/MED/28637687

15 February 2018

published in

Clinical Cancer Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6939669&resulttype=core&format=json

13 May 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6939669&resulttype=core&format=json

13 May 2020

issue

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6939669&resulttype=core&format=json

13 May 2020

page(s)

5802-5813

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6939669&resulttype=core&format=json

describes a project that uses

13 May 2020

Cytoscape

1 reference

9 June 2022

https://europepmc.org/search?query=(METHODS:'Cytoscape')

inferred from PubMed Central ID database lookup

limma

1 reference

22 June 2022

https://europepmc.org/article/PMC/6939669

inferred from PubMed Central ID database lookup

cites work

Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes

1 reference

12 December 2020

Targeting CDK4 and CDK6: From Discovery to Therapy

1 reference

12 December 2020

p16-Cdk4-Rb axis controls sensitivity to a cyclin-dependent kinase inhibitor PD0332991 in glioblastoma xenograft cells

1 reference

12 December 2020

Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables

1 reference

12 December 2020

Identification of a Myc-dependent step during the formation of active G1 cyclin-cdk complexes.

1 reference

12 December 2020

Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial

1 reference

12 December 2020

Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma

1 reference

12 December 2020

Cytoscape: a software environment for integrated models of biomolecular interaction networks

1 reference

12 December 2020

Molecular subgroups of medulloblastoma: the current consensus

1 reference

12 December 2020

Evasion of Cell Senescence Leads to Medulloblastoma Progression

1 reference

12 December 2020

Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum

1 reference

12 December 2020

Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma

1 reference

12 December 2020

Identification of G1 kinase activity for cdk6, a novel cyclin D partner

1 reference

12 December 2020

Therapeutic targeting of the cyclin D3:CDK4/6 complex in T cell leukemia.

1 reference

12 December 2020

A synthetic lethal interaction between K-Ras oncogenes and Cdk4 unveils a therapeutic strategy for non-small cell lung carcinoma.

1 reference

12 December 2020

The proto-oncogene c-myc acts through the cyclin-dependent kinase (Cdk) inhibitor p27(Kip1) to facilitate the activation of Cdk4/6 and early G(1) phase progression

1 reference

12 December 2020

Chemoproteomics Reveals Novel Protein and Lipid Kinase Targets of Clinical CDK4/6 Inhibitors in Lung Cancer.

1 reference

12 December 2020

Role of MYC in Medulloblastoma.

1 reference

12 December 2020

The requirement for cyclin D function in tumor maintenance

1 reference

12 December 2020

Efflux transporters at the blood-brain barrier limit delivery and efficacy of cyclin-dependent kinase 4/6 inhibitor palbociclib (PD-0332991) in an orthotopic brain tumor model

1 reference

12 December 2020

Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma.

1 reference

12 December 2020

C-MYC expression in medulloblastoma and its prognostic value.

1 reference

12 December 2020

Hemangiosarcomas, medulloblastomas, and other tumors in Ink4c/p53-null mice.

1 reference

12 December 2020

Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma.

1 reference

12 December 2020

Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma

1 reference

12 December 2020

Medulloblastoma comprises four distinct molecular variants

1 reference

12 December 2020

Brain Exposure of Two Selective Dual CDK4 and CDK6 Inhibitors and the Antitumor Activity of CDK4 and CDK6 Inhibition in Combination with Temozolomide in an Intracranial Glioblastoma Xenograft

1 reference

12 December 2020

Cell cycle-based therapies move forward.

1 reference

12 December 2020

Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations

1 reference

12 December 2020

CDK inhibitors: positive and negative regulators of G1-phase progression

1 reference

12 December 2020

Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition

1 reference

12 December 2020

DiSCoVERing Innovative Therapies for Rare Tumors: Combining Genetically Accurate Disease Models with In Silico Analysis to Identify Novel Therapeutic Targets

1 reference

12 December 2020

The molecular classification of medulloblastoma: driving the next generation clinical trials

1 reference

12 December 2020

Quantitative analysis of PD 0332991 in mouse plasma using automated micro-sample processing and microbore liquid chromatography coupled with tandem mass spectrometry.

1 reference

12 December 2020

DrugBank: a comprehensive resource for in silico drug discovery and exploration

1 reference

12 December 2020

Phase I, dose-escalation trial of the oral cyclin-dependent kinase 4/6 inhibitor PD 0332991, administered using a 21-day schedule in patients with advanced cancer

1 reference

12 December 2020

Phase I study of PD 0332991, a cyclin-dependent kinase inhibitor, administered in 3-week cycles (Schedule 2/1).

1 reference

12 December 2020

PD-0332991, a CDK4/6 inhibitor, significantly prolongs survival in a genetically engineered mouse model of brainstem glioma

1 reference

12 December 2020

Pharmacologic inhibition of cyclin-dependent kinases 4 and 6 arrests the growth of glioblastoma multiforme intracranial xenografts

1 reference

12 December 2020

A CDK4/6-Dependent Epigenetic Mechanism Protects Cancer Cells from PML-induced Senescence.

1 reference

12 December 2020

Aging, cellular senescence, and cancer

1 reference

12 December 2020

Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts.

1 reference

12 December 2020

User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability

1 reference

12 December 2020

Curating the innate immunity interactome

1 reference

12 December 2020

Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome

1 reference

12 December 2020

Sleeping Beauty mutagenesis in a mouse medulloblastoma model defines networks that discriminate between human molecular subgroups

1 reference

12 December 2020

Regression of experimental medulloblastoma following transfer of HER2-specific T cells

1 reference

12 December 2020

Subgroup-specific structural variation across 1,000 medulloblastoma genomes

1 reference

12 December 2020

Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins

1 reference

12 December 2020

10.1158/1078-0432.CCR-16-2943

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6939669&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6939669&resulttype=core&format=json

13 May 2020

1 reference